Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06399900 · ClinicalTrials.gov registry record · NA

ENhancing Exercise with LIGHT to Improve Functioning in PAD

A NA study of Aging and Peripheral Artery Disease, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT06399900 is a NA study of Aging and Peripheral Artery Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 32 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06399900, a NA study of Aging and Peripheral Artery Disease, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The ENLIGHTEN PAD Trial will collect preliminary data to test whether daily 660 nm light treatment of the lower extremities immediately before home-based walking exercise sessions improves six-minute walk distance at 4-month follow-up, compared to sham light, in people with lower extremity peripheral artery disease (PAD).

Interventions

  • DEVICE Far red light therapy
  • DEVICE Sham light therapy
  • BEHAVIORAL Home-based walking exercise

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-08-12
Est. Completion 2027-01-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT06399900

The ClinicalTrials.gov registry entry for NCT06399900 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 3 interventions - of which Far red light therapy is the first listed.

NCT06399900 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06399900 about?

NCT06399900 is a clinical study titled "ENhancing Exercise with LIGHT to Improve Functioning in PAD". The ENLIGHTEN PAD Trial will collect preliminary data to test whether daily 660 nm light treatment of the lower extremities immediately before home-based walking exercise sessions improves six-minute walk distance at 4-month follow-up, compared to sham light, in people with lower extremity periphera...

What is the current status of trial NCT06399900?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-08-12. Estimated completion is 2027-01-31.

What conditions does trial NCT06399900 study?

This clinical trial studies the following conditions: Aging, Peripheral Artery Disease, Peripheral Vascular Disease, Walking, Difficulty.

What interventions are being tested in trial NCT06399900?

The interventions under investigation include: Far red light therapy (DEVICE), Sham light therapy (DEVICE), Home-based walking exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06399900?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06399900 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.